Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Get news by email or subscribe to our news feeds.
Health Highlights: Aug. 4, 2020
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Medicare Should Expand Telehealth: Trump President...
Remote Weight-Loss Program Optimized to Cut Costs, Maximize Results
TUESDAY, Aug. 4, 2020 -- A new, remote weight-loss program from Northwestern Medicine, called Opt-IN, yields maximum weight loss for the lowest price and less...
Program Cuts Outpatient Antibiotic Rx for Peds Respiratory Infections
TUESDAY, Aug. 4, 2020 -- A distance learning program is effective for reducing outpatient prescribing for pediatric acute respiratory tract infection (ARTI)...
AI-Enabled ECG Can Identify Left Ventricular Systolic Dysfunction
TUESDAY, Aug. 4, 2020 -- For patients presenting to the emergency department with dyspnea, an artificial intelligence-enabled electrocardiogram (AI-ECG) can...
WTC Responders With Impaired Cognition Have Brain Changes
TUESDAY, Aug. 4, 2020 -- World Trade Center (WTC) responders with cognitive impairment have reductions in cortical thickness (CTX), while posttraumatic stress...
Probiotics Not Recommended for Most Digestive Conditions
TUESDAY, Aug. 4, 2020 -- Probiotics are not recommended for most digestive conditions, according to a clinical practice guideline issued by the American...
Coronavirus Cases Now Climbing in the Midwest
TUESDAY, Aug. 4, 2020 -- Midwestern states are starting to see surges in coronavirus cases, just as Southern and Western states are scrambling to contain their...
Aggressive Cancer Diagnosed for First Time in a Dinosaur
TUESDAY, Aug. 4, 2020 -- Scientists for the first time have identified an aggressive bone cancer in a dinosaur that lived nearly 77 million years ago. The...
Many Older Americans Staying Strong in the Pandemic
TUESDAY, Aug. 4, 2020 -- Older Americans are feeling stressed by COVID-19 and prolonged social isolation, but they're also showing their resiliency, a new...
November Election Can Be Held Safely, Experts Contend
MONDAY, Aug. 3, 2020 -- With the 2020 presidential election just three months away, new research suggests an election can be held safely if stringent steps are...
FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
PLANEGG/MUNICH, Germany - August 1, 2020 and WILMINGTON, Del. - July 31, 2020 MorphoSys AG NASDAQ:MOR) and Incyte (Nasdaq:INCY) today announced that the U.S....
FDA Approves Xeglyze (abametapir) Lotion for the Treatment of Head Lice
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE) July 27, 2020 --Dr. Reddy’s Laboratories Ltd. today announced approval of Xeglyze (abametapir)...
scPharmaceuticals Announces FDA Acceptance of Furoscix New Drug Application Resubmission
BURLINGTON, Mass.--(BUSINESS WIRE)--Jul. 27, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
FDA Approves Tecartus (brexucabtagene autoleucel) as the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma
SANTA MONICA, Calif.--(BUSINESS WIRE)--Jul. 24, 2020-- Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA)...
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD
24 July 2020 -- AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance...
FDA Approves Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
DUBLIN, July 22, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved...
Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis
VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE) July 21, 2020 -- Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia”...
Orphazyme Completes Rolling Submission of New Drug Application To U.S. FDA for Arimoclomol for Niemann-Pick Disease Type C
Copenhagen, Denmark, July 20, 2020 – Orphazyme A/S (ORPHA.CO), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response in order...
FDA Grants Priority Review to Merck’s New Drug Application for Vericiguat
KENILWORTH, N.J.--(BUSINESS WIRE) July 16, 2020 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and...
Mallinckrodt Announces U.S. Food and Drug Administration (FDA) Advisory Committee Voted to Recommend Terlipressin for Approval to Treat Patients with Hepatorenal Syndrome Type 1 (HRS-1)
DUBLIN, July 15, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that the Cardiovascular and Renal Drugs...
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-Clinical Studies
NEW BRUNSWICK, N.J., July 30, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against...
Nirsevimab Reduced Respiratory Syncytial Virus Infections and Hospitalisations in Preterm Infants in Phase IIb Trial
30 July 2020 -- Nirsevimab showed a significant reduction in medically-attended lower respiratory tract infections (LRTI) and hospitalisations caused by...
BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness
TARRYTOWN, N.Y., July 29, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the Biomedical Advanced Research and...
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
NEW YORK & MAINZ, Germany--(BUSINESS WIRE) July 27, 2020 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the start of a global...
Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN
CAMBRIDGE, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced that its novel drug candidate, nipocalimab,...
Older Articles by News Type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
